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1. Introduction
Hydrogels formed by chemical or physical cross -
linking are three dimensional structures made from
hydrophilic polymers that can imbibe a considerable
amount of water while maintaining their integrity.
The study of hydrogels as drug delivery systems
and biomedical devices has been extensive over the
last few decades because of their biocompatibility
properties and control of solute transport [1–3]. More
recently, sensitive hydrogels prepared with addi-
tional functions have gained considerable attention.
In this way, the incorporation of stimuli-sensitive
monomers in the chain of the hydrogel can improve
the performance of these materials by increasing
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responsiveness in a particular medium [4]. These
hydrogels, often called ‘intelligent’ or ‘smart’ hydro-
gels, can undergo relatively large and abrupt, physi-
cal or chemical modification in response to changes
in environmental conditions such as pH, ionic
strength, temperature or in presence of specific chem-
ical compounds [5, 6]. For this reason, they are usu-
ally known as environmentally sensitive hydrogels.
These types of stimuli-responsive polymers have
the property to swell, shrink, bend, or degrade in
response to changes in the environmental condi-
tions.
Due to its properties, sensitive hydrogels have been
proposed for a number of applications like drug
delivery, separation techniques and sensors [7–9].
Recently sensitive hydrogels have been also pro-
posed for ocular drug delivery systems in order to
improve the ocular bioavailability of drugs, and to
reduce the appearance of side effects [10]. In this
case, within topical application of drugs, the pres-
ence of ocular compact barrier in the corneal and con-
junctival epithelia of the eye, along with the dynam-
ics of the lacrimal system, hinder the drug absorption
into the intraocular area [11, 12]. The use of sensi-
tive polymeric hydrogel allows to extend the resi-
dence time in the eye and to increase the percentage
of drug absorbed [13].
In recent years research was mainly focusing to the
technological innovations in this field with the aim
to design hydrogels for a specific use as ocular drug
delivery systems or in order to improve the uptake
capacity and the release performance of these sys-
tems [8, 11, 14] although few works have  been pub-
lished  using intelligent systems.
Of particular interest in this work it is the use of
smart polymers as ocular drug delivery systems, and
specifically the use of pH-sensitive hydrogels. This
kind of material has been extensively studied as drug
delivery systems for different applications, mainly
due to the fact that they can release the drug selec-
tively according to the pH of the medium [15]. In
the human body there are variations in the physio-
logic pH values in both normal and pathological con-
ditions, for example the gastrointestinal tract pres-
ents heterogeneous environments with different pH
values ranging from 1 to 7.5 [16]. These conditions
allow pH-sensitive hydrogels to release the desired
drug in the right place [17]. In case of ophthalmo-
logic therapies the release should be close to the
medium ocular pH of 7.45 [18, 19].
The potential use of stimuli-sensitive hydrogels
allow not only a spatial control but also a temporal
control; i.e. during the period of time when the pH
value is outside the normal range. These pH-sensi-
tive hydrogels as drug delivery systems are poten-
tially useful in ophthalmic therapies due to the fact
that deviations from normal pH were observed in
some disease processes, for example in ocular rosacea
(an inflammation of the eye) [20]. Ocular pH change
also in allergy and other conditions such as dry eye
and bacterial infections [21]. Therefore these systems
may be useful for controlling drug release in response
to the pathological conditions.
Moreover, pH-sensitive hydrogels are normally
prepared by adding pendant acidic or basic func-
tional groups to the polymer backbone by including
during the polymerization monomers like N-(3-
aminopropyl)methacrylamide, 2-(dimethylamino)
ethyl methacrylate, methacrylic acid and 2-amino -
ethyl methacrylate and 2-hidroxyethyl methacrylate
(HEMA) for ionic type and butyl methacrylate, allyl
diglycol carbonate, diallyl phthalate, and methyl
methacrylate as neutral hydrophobic types [22–27].
Recently, we have reported the synthesis of a new
pH-sensitive hydrogel based on 2-(diisopropylamino)
ethyl methacrylate (DPA) and 2-hidroxyethyl metha -
crylate (HEMA), p(HEMA-co-DPA) [28] with good
film properties depending on the monomer ratio.
In this contribution, we evaluate the properties of
these pH-sensitive hydrogels with different propor-
tions of HEMA and DPA and two degrees of cross-
linking as potential materials for using in ocular
drug delivery systems. Owing to this material, physi-
cal or chemical modifications can undergo in response
to changes in environmental conditions, it is neces-
sary to characterize the morphology and swelling
behavior in function of the pH to understand and
predict the drug’s release rate. In this work we stud-
ied the swelling behavior of hydrogels in a range of
pH from 5.5 to 8.4 which is the used range in eye drop
solutions, and at the average ocular temperature of
34.5±0.5°C [29, 30]. We have determined pKa val-
ues of different copolymers’ compositions, and also
we have studied morphological changes on hydrated
samples at different medium pH values using Scan-
ning Electron Microscopy (SEM). Their potential
for ophthalmological application as pH-sensitive
control drug release system was investigated in
vitro using Rhodamine 6G Chloride (Rh6G, Mw =
479.01) as a model drug, because it is stable in
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aqueous solutions (water solubility at 25°C =
20 mg·L–1) and it is easily detected by its UV absorp-
tion. Effects of HEMA/DPA contents and different
cross-linking degrees on drug uptake and release
behavior were studied at different pH values under
ocular conditions. Despite the number of recent
studies incorporating active agent into hydrogels
[31], the interaction between the matrix and the
drug receive limited attention in the literature and it
is often overlooked [4]. That is why in this work we
intended to analyze also hydrogels’ performance
and their interactions with the model drug by using
FTIR and SEM analysis.
2. Experimental section
2.1. Materials
2-Hydroxyethyl methacrylate (HEMA, 97%) and
the cross-linker, ethylene glycol dimethacrylate
(EGDMA, 98%), were purchased from Sigma-
Aldrich, USA, while 2-(diisopropylamino)ethyl
methacrylate (DPA) were purchased from Scientific
Polymers Products, USA. Darocur TPO (97%) from
Sigma-Aldrich, USA, was used as the initiator. The
phosphate buffer solutions (PBS) were prepared
from standard chemicals. The study of the hydro-
gels as drug delivery systems was performing using
Rhodamine 6G Chloride (Rh6G, 95%), from Sigma-
Aldrich, USA, as model drug (Figure 1). This mol-
ecule is frequently used for those studies because it
has a similar chemical structure compared to drugs
[32, 33]. Additionally Rh6G have good solubility in
water (20 g/L at 25°C), chemical stability and it is
easy detectable with UV-visible spectroscopy.
2.2. Polymer synthesis
The synthesis of DPA homopolymer and copoly-
mers was performed in bulk by free radical poly-
merization using diphenyl (2,4,6-trimethylbenzoyl)-
phosphine oxide (Darocur® TPO) as photo-initiator.
Different ratios of HEMA/DPA monomers (namely
100/0, 90/10 and 70/30) and 1 and 3 wt% of cross-
linker (relative to the whole monomer) were mixed
with 1% w/v of photo-initiator and irradiated with
an UV-lamp (Rayonet RPR3500, USA). Films with
180±30 µm of thickness were cut into circular pieces
of 13 mm of diameter with a cork borer and dried at
25.0°C for 48 h before use. Film samples were
denoted by using a short-hand notation HDX/Y-n,
where X and Y denote the HEMA (H) and DPA (D)
ratio respectively, and n denote the amount of cross-
linker. More details of synthesis and experimental
procedures can be found in a previous paper [28].
The experimental composition ratios in copolymers
HD90/10-1, HD90/10-3, HD70/30-1 and HD70/30-3
are 82/18, 85/15, 66/34 and 65/35, respectively and
they were determined by IR spectroscopy following
the reported method by Canto and Pessan [34].
2.3. Swelling degree
For the determination of the swelling degree, dry
samples were immersed in phosphate buffer solu-
tions (PBS, 0.1 M) at the desired pH (ranging from
5.5 to 8.4) at the average ocular temperature of
34.5°C [30]. At regular periods of time samples were
removed from the aqueous solution, blotted with
filter paper to remove surface liquid, weighed and
returned to the same container until reaching a con-
stant weight. The equilibrium swelling degree (Qe)
was calculated using Equation (1):
                                 (1)
where Wd is the weight of the dry film and We is the
weight of swollen film at equilibrium. Experiments
were performed in triplicate.
2.4. Drug loading
Films were loaded with Rh6G by soaking the dry
films into 20 mL of the drug solution (50 mg/L) in
PBS at pH 6.5 and 8.4, and at 25.0°C, until the equi-
librium was reached (see below). For practical pur-
poses the loading time was unified in 7 days for all
samples. Drug uptake kinetics were followed by
measuring the absorbance of the solution by UV-
visible spectroscopy at 348 nm using a Fluorat®-02-
Panorama spectrophotometer, Lumex, Russia. Sam-
ples loaded with Rh6G were denoted by adding the
Qe 3, 4 5 We 2 WdWd ~100
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Figure 1. Chemical structure of Rhodamine 6G
letter R in brackets to the name of the sample (e.g.
HD90/10-1(R)).
The partition coefficient of the drug through the
hydrogel was calculated using the modified method
of Sato and Kim [35, 36], as shown by Equation (2):
                                             (2)
where Vs is the volume of solution, Vm is the vol-
ume of polymer film, C0 is the initial solute concen-
tration and Ce is the solute concentration in the solu-
tion at the equilibrium time.
2.5. Scanning electron microscopy (SEM)
Hydrogels’ morphology and drug distribution were
observed by Scanning Electron Microscopy (SEM)
with an FEI – Quanta 200 (The Netherlands) instru-
ment, in high vacuum mode and operated at 15 or
20 kV acceleration voltage. p(HEMA-co-DPA) and
pHEMA hydrogels were equilibrated during 24 h in
different buffer solutions and then were frozen at 
–40°C in an alcoholic solution followed lyophiliza-
tion under vacuum for 24 h. In order to prevent sam-
ple-charging effects during the observation, frac-
tured pieces of samples were mounted onto the sur-
face of an aluminum SEM specimen holder and sput-
ter-coated with a thin overlayer of gold before obser-
vation. Films loaded with Rh6G were prepared in
the same way.
2.6. Infrared spectroscopy (FTIR)
FTIR spectra were measured in transmission mode
using a FTIR Nicolet 380 spectrometer, Thermo Sci-
entific, USA. Samples were loaded with Rh6G until
the equilibrium was reached and then powdered and
mixed with KBr; disks were formed by pressing.
FTIR spectra were obtained by recording 64 scans
between 4000 and 400 cm–1 with a resolution of
4 cm–1. Spectra processing was performed using the
software EZ Omnic.
2.7. Drug release experiments
Release experiments of Rh6G loaded p(HEMA-co-
DPA) films were conducted in media of different pH
values. Drug loaded films were removed from the
loading solution, wiped with filter paper to remove
surface liquid and placed directly into the release
solution. Drug release experiments were performed
by immersing p(HEMA-co-DPA) films into 20 mL of
PBS (0.1 M) at 34.5°C. The dynamic drug concen-
tration in the PBS solution was monitored by meas-
uring the absorbance at 526 nm. The Rh6G concen-
tration released as a function of time (t) was adjusted
to a power-law type relationship [37, 38] using the
equation of Ritger-Peppas (Equation (3)):
                                                            (3)
Here Mt and Me are the cumulative amount of drug
released after a time t and at infinite time, respec-
tively, while k is a constant related to kinetic behav-
ior and experimental conditions and n is the expo-
nent depending on the release process. Data were
fitted only up to 60% of drug release in order to
apply Equation (3).
Parameters k and n were calculated from the inter-
cept and the slope of Equation (4):
                                            (4)
For Fickian diffusion processes, Equation (5) applies
to calculate the diffusion coefficient (Dip), where L
is the thickness of the film:
                                              (5)
3. Results and discussion
3.1. Swelling studies
In pH-sensitive systems the release rate of the drug
is regulated by several factors as swelling degree,
drug-matrix interaction, water content and the ini-
tial PA concentration [39, 40]. However the swelling
behavior as a function of pH has a principal role in
drug release regulation, which makes this technique
to be an important tool to predict the drug’s rate
release. In this section swelling results of hydrogels
in a range of pH from 5.5 to 8.4 and the determina-
tion of pKa values corresponding to the different com-
positions of the copolymers are presented. Figure 2
shows the equilibrium swelling degree for different
HEMA/DPA ratios with 1 and 3 wt% of cross-linker
at different pH values.
Hydrogels of pHEMA show a slight increase in the
swelling degree when increasing the pH from 5.5 to
8.4. However, the difference of swelling degree over
the pH range studied in this work is rather low. Sim-
ilar results were observed by Brannon-Peppas and
Peppas [41]. On the other hand, hydrogels of
p(HEMA-co-DPA) show a significant increase of
Mt
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5 4 a Dipt
pL2
b 1>2
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the swelling when the pH decrease below 7.40. This
effect is directly proportional to the amount of DPA
co-monomer present in copolymers, and is mainly
attributed to the protonation of the tertiary amino
groups. At pH below 7.40, amino groups become
protonated and the electrostatic repulsion, between
these ionized groups, expands the network space
and increases its internal volume, allowing water to
get into the matrix [14, 42, 43]. The equilibrium of
swelling is reached around pH 6.0. At basic pH,
above 7.40, the effect is reversed, the swelling degree
decreases with the amount of DPA present in the
hydrogel. In this case functional groups of HEMA
and DPA are able to form hydrogen-bonds [28],
which in turn generate a proximity between polymer
chains and consequently reduce the free space avail-
able for water molecules. Additionally, swelling
values decrease also due to the hydrophobic nature
of the unprotonated DPA moiety at basic pH.
For all HEMA/DPA ratios the cross-linking density
does not modify the sensitivity to respond to pH
changes but it affects the swelling degree. For high
proportion of cross-linking, the swelling decreases for
a given pH. This behavior is due mainly to two fac-
tors: first a matrix with higher crosslink density has
less free space to be occupied by water; and second
the crosslink degree generates a more rigid tridi-
mensional structure which limits the chains’ mobil-
ity and increases the elastic force that opposes to
the expansion of the hydrogel’s internal space [44].
The apparent copolymers’ pKa can be estimated by
using swelling experiments at different pHs. In the
pH range of 6.5 to 7.4 the swelling of the hydrogel
decreases almost linear when increasing pH. In this
range of pH, both the protonated and unprotonated
form of the DPA moiety are present inside the poly-
mer matrix acting as a buffer system in the hydro-
gel. Under these conditions, the Handeson-Hassel-
balch equation (Equation (6)) can be applied to
determine the apparent pKa:
                                                        
                                                                             (6)
The apparent pKa of the hydrogel buffer system can
be determined from the pH value for which the frac-
tion between these two ionic forms is one. This cor-
responds to the point located in the middle of the
swelling curve presented in Figure 2. The apparent
pKa values are show in Table 1 and range from 6.80
to 7.17 depending on polymers’ composition and
their crosslinking degree due to the availability of
hydrogel’s ionic groups to act as buffer system [29].
3.2. Drug uptake
Figure 3 shows the cumulative uptake of Rh6G as a
function of immersion time for pHEMA and
p(HEMA-co-DPA) films in PBS at pH 6.5 (Fig-
ure 3a) and 8.4 (Figure!3b).
At pH 6.5 by increasing the DPA content, the Rh6G
kinetic uptake increases (Figure 3a). At this pH the
swelling degree of hydrogels containing DPA (see
above) favors the incoming of the drug into the film
due to the increase of the network space and the dif-
fusion of the aqueous solution, allowing the water
soluble drug to get into the matrix. However, the
final uptake and the partition coefficient at acid pH
for pure pHEMA films are higher than that for the
copolymer films (Table 2). This behavior can be
explained in terms of an increased electrostatic repul-
sive interaction between the protonated tertiary amine
groups of the polymer matrix and the positive charge
on the Rh6G cation when increasing DPA content
(see Figure 1 for the Rh6G chemical structure).
1log c unprotonated state of tertiary amine group
protonated state of tertiary amine group
dpH 5 pKa 1
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Figure 2. Equilibrium swelling degree for copolymers with
different HEMA/DPA ratios, with 1 and 3 wt% of
cross-linker as a function of pH at 34.5°C
Table 1. Apparent pKa values for copolymers at 34.5°C
Copolymers pKa SD
HD70/30-1 7.01 0.06
HD70/30-3 6.94 0.07
HD90/10-1 6.87 0.08
HD90/10-3 6.80 0.06
On the opposite, at pH 8.4, by increasing the DPA
content, the Rh6G kinetic uptake decreases (Fig-
ure 3b), and it is slower than at acid pH. The equi-
librium time ranges from 150 minutes for HD70/30
to 6 days for HD100/0, when loading is at pH 6.5;
and 2 days for HD70/30 and 6 days for HD100/0,
when loading is at pH 8.4.
At pH 8.4 the increment on the DPA content causes
a decrease in the swelling degree and consequently
a decrease in the network space that retard the drug
incorporation. However, the final uptake of Rh6G
at pH 8.4 is higher than at pH 6.5. At acidic pH, the
swelling increases due to the protonation of the
functional group of the DPA, but the incorporation
of Rh6G decreased by the electrostatic repulsion
between the tertiary amine of DPA (partially proto-
nated) and the cation of Rhodamine 6G. At basic pH,
the electrostatic repulsion is less pronounced due to
the decrease in the degree of ionization of the matrix,
and hence the incorporation of Rh6G in the copoly-
mers is higher. In conclusion, the amount of Rh6G
incorporated into the polymer is inversely propor-
tional with the swelling of the hydrogel, and depends
mainly on the medium pH and the interaction
between the drug and the copolymers’ matrix.
At both pH values the total uptake Rh6G is higher
for pure pHEMA homopolymer than for the copoly-
mers. By including DPA monomer, the total amount
of OH groups present in the hydrogel is reduced (as
verified by FTIR) and, consequently, the available
interaction sites decrease and then the number of
Rh6G molecules incorporated also decreases (see
Table 2).
As expected from the swelling data, increasing the
degree of cross-linking from 1 to 3 wt% reduces the
amount of Rh6G incorporated in all cases. Thus it is
possible to modify the final incorporation of Rh6G
changing the pH of the load medium instead of modi-
fying the loading time. This allows regulating the
amount of loaded drug into the hydrogel depending
on the dose that is to be released.
3.3. SEM characterization
SEM is probably the best method for characterizing
the hydrogel structure, especially in drug delivery
systems because it offers information of surface
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Figure 3. Cumulative uptake of Rh6G as a function of immersion time for pHEMA and p(HEMA-co-DPA) films in PBS at
pH 6.5 (a) and 8.4 (b)
Table 2. Final mass uptake and partition coefficient (Kd) of Rh6G at pH 6.5 and 8.4
SD: standard deviation; n: number of measure between 2–4.
HEMA/DPA Crosslinking[wt%]
Rh6G uptake (mg/g-dryfilm)
pH 6.5 pH 8.4
Mean SD Kd Mean SD Kd
100/0
1 27.4 0.1 902 31.8 0.3 1210
3 24.6 2.0 761 31.4 0.9 1066
90/10
1 6.3 0.6 101 23.7 0.8 694
3 5.2 1.6 76 20.0 0.2 509
70/30
1 4.7 1.1 26 18.0 0.9 491
3 3.7 0.9 28 15.1 0.2 358
porosity, amorphous and crystalline characteriza-
tion, particle size, phase separation and in particular
the active principle ingredient distribution in the
structure [45]. Morphologic changes of lyophilized
pH-responsive hydrogels, after exposure them to
aqueous solutions of different pH values (6.5 and
8.4), have been examined by SEM technique. Images
are shown in Figure 4.
The surface of the hydrogel HD70/30-1 at pH 6.5
shows an open morphology state with a porous struc-
ture, thin walls and a predominant free space as a con-
sequence of the matrix expansion at this pH. At pH
to 8.40 a collapsed state is observed with almost a
featureless structure due to lower swelling degree and
a more hydrophobic polymer at this pH. For hydro-
gel HD90/10-1 the surface also shows a morpho-
logic change with the pH value. At pH 6.50 a homo-
geneous pore distribution on the surface is observed,
while at pH 8.40 a non-porous and compact surface
is appreciated. When the DPA content is higher, the
equilibrium swelling increases, which led to more
and larger pores in hydrogels as obtained from
lyophilization, being 5±2 µm for 10 wt% and 7±2 µm
for the 30% of DPA. By comparing those values with
the mesh sizes of conventional hydrogels, smaller
than 100 nm [46, 47], both systems have a higher
pore size. For hydrogel HD100/0-1 no changes with
pH are appreciated and in all cases a compact sur-
face is observed. The incorporation of DPA confers
pH-responsive properties to the polymer, as noted
in swelling studies; therefore changing the medium
pH not only changes the film volume but also the
morphology. In the case of sample with higher con-
centration of cross-linker (3 wt%) the same trend in
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Figure 4. SEM images of hydrogel HD70/30-1, HD90/10-1 and HD100/0-1 at pH!6.5 and pH 8.4
Figure 5. SEM images of hydrogel HD70/30-1(R) loaded at pH 6.5: a) surface, b) inside the matrix; and at pH 8.4: c) inside
the matrix, d) surface
morphological changes with the medium pH is
observed (data not shown).
In Figure 5 are presented SEM images of samples
HD70/30-1(R), loaded with RhG6 at pH 6.5 and
8.4.
SEM images of the hydrogel 70/30-1(R) loaded at
both pHs (6.5 and 8.4) show the presence of Rh6G.
In the case of loading at pH 6.5, the surface (Fig-
ure 5a) shows a greater accumulation of Rh6G
unlike inside the matrix (Figure 5b). While at pH
8.4 the Rh6G is observed both inside the matrix and
on the surface (Figure 5c and 5d respectively).
Rh6G molecules have lower affinity for the matrix
of the copolymer HD70/30-1 at acidic pH, and there-
fore incorporation is lower and mainly superficial.
3.4. FTIR spectroscopy
Figure 6 shows the FTIR spectra of HD70/30-1 and
HD100/0-1 with (samples labeled R) and without
Rh6G. The main differences in the high wavenum-
bers region of the spectrum are the increasing inten-
sity of the stretching band of the O–H group
(3414 cm–1). The existence of an interaction between
Rh6G and-OH groups through the group =N+(H) is
known, therefore interactions between Rh6G and
pHEMA [48] are also expected. The C–H stretching
region is also different. Upon the copolymerization
with DPA, the –CH2– and –CH3 bands of the stretch-
ing modes of pure pHEMA observed at 2986, 2951
and 2882 cm–1 (Figure 6) are overlapped with those
of the DPA monomer and peaks become broader. In
the C–H stretching region of the HD70/30-1 copoly-
mer spectrum, a broad band centered at 2965 cm–1
is observed. These wavenumbers correspond to the
characteristic peak of the methine group in the iso-
propyl moiety ((CH3)2–CH–) [49]. However after
Rh6G loading the peak pattern of the FTIR changed
showing peaks at 2985, 2950 and 2888 cm–1. These
peaks values are close to the C–H stretching of the
pure pHEMA, suggesting that the peak of the stretch-
ing of the methine group at 2965 cm–1 shifted, prob-
ably to higher wavenumbers and overlapping with
the 2985 cm–1 peak due to the loss of interaction
between the lone electron pair of tertiary amine
group of DPA with the OH of pHEMA [28] and the
formation of new hydrogen bonds with the Rh6G
molecules [48].
In the 2000–400 cm–1 region the new features after
Rh6G loading are mainly in low wavenumbers side
of the C=O (free) stretching band (located at
1730 cm–1), namely a band at 1651 cm–1 from the
contribution of bonded carbonyl groups of Rh6G,
and small peaks at 1647 and 1606 cm–1 from the
xanthene ring of this molecule (see [50, 51] for
more details of Rh6G spectrum). These contribu-
tions are more evident in HD100/0-1 film due to its
higher loading of Rh6G. In HD70/30-1 film, the
band of the isopropyl group ((CH3)2–CH–) of DPA
moiety, observed at 1336 cm–1 in the unloading
film, shows lower intensity after Rh6G loading.
Minor differences are also observed in the 1000–
880 cm–1 region, where the contribution of the
absorption bands of Rh6G is negligible. This region
is associated to C–C modes of the carbon backbone
of the polymer.
In summary, observed differences in the FTIR spec-
tra between loaded and unloaded films indicate that
Rh6G molecules are interacting with polymer chains,
probably with both parts of the copolymer (HEMA
and DPA moieties) by hydrogen bonding or through
dipole–dipole interaction [52].
3.5. Drug release
3.5.1. Effect of medium pH
Figure 7 shows the cumulative concentration of
Rh6G released at 34.5°C in PBS for different pH
values as a function of time for HD70/10-1,
HD90/10-1 and HD100/0-1 loaded at pH 8.4. This
pH was chosen because the drug uptake is the high-
est found in this work (see section 3.2 and Table 2.)
In copolymers of HEMA/DPA release kinetics of
Rh6G varies significantly with changing the pH of
the medium, as the pH increases the release becomes
faster. This effect is related to the swelling property
of these hydrogels when changing the medium pH.
At basic pH the matrix is closed and the swelling is
low, by acidifying the medium, the hydrogel swells
and the release rate of the Rh6G increases as well as
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Figure 6. FTIR spectra for films: HD100/0-1, HD100/0-
1(R), HD70/30-1 y HD70/30-1(R)
the pore size of the hydrogel [53]. In the case of
HD70/30-1 the effect of the pH on the release kinet-
ics is much more pronounced than in HD90/10-1
copolymer due to the higher amount of DPA. At acid
pH, the electrostatic repulsion between the tertiary
amine groups of the DPA partially protonated and
the Rh6G cation favors the released of this drug.
Drug release behavior at different pH values is also
consistent with morphologic characteristics observed
in SEM images (Figure 3), the higher the pore size
of the hydrogel, the faster is the released of the
drug.
The total amount of Rh6G released from pHEMA
film is incomplete (about 30% is released) and it is
almost pH independent as a consequence of the
interaction of the Rh6G molecule with the polymer
functional groups, as observed by FTIR spectro -
scopy. Similar results were obtained in other cases
of interaction between the drug and the matrix [54–
56]. Although, for DPA containing polymers, the total
Rh6G released at pH 6.5 (about 90%) is higher than
at pH 8.4 (about 40%). At acidic pH, the tertiary
amine groups are partially protonated and the elec-
trostatic interaction with the Rh6G cation impels
the release from the matrix. At pH 8.4, the electro-
static repulsion is no longer acting and, therefore,
the driving force is reduced.
Table 3 shows the kinetics parameters (k and n) of
the experimental data of Figure 7, calculated using
Equation (4), and the diffusion coefficient (Dip),
using Equation (5).
For pure pHEMA samples n values indicate a Fick-
ian transport from pH 6.5 to 8.4. Highly soluble
drugs, like Rh6G, typically exhibit Fickian release
from hydrogels, and the release profile is mainly
dependent upon the solubility and diffusion kinetics
of the drug. For the hydrogel HD90/10-1, the n val-
ues are between 0.5 and 1, indicating anomalous
transport, and a domination of relaxation process
over diffusion. In the case of HD70/30-1, n values
varies significantly with the pH, at pH 6.5 and 7.4 are
between 0.5 and 1 while at pH 8.4 is low than 0.5.
For higher pHs experimental values suggest a dif-
ferent mechanism transport, that is, the presence of
another process besides passive diffusion. Above
pKa the deprotonation is accompanied by a de-
swelling of the hydrogel (see Figure 2).
The Dip value of Rh6G in water at 25°C is
4.14·10–6 cm2/s and as expected, all values found in
this work for Fickian diffusion are lower than this
one [57].
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Figure 7. Cumulative concentration of Rh6G released as a function of time for HD70/10-1, HD90/10-1 and HD100/0-1
(loaded at pH 8.4) at 34.5°C in PBS for different pH values
Table 3. Parameters (k, n) calculated from the fit of Equa-
tion (4), and diffusion coefficients (Dip) calculated
from Equation (5) for the Rh6G release curves
from Figure 7
Samples pH R2 k·10
2
[cm–1] n
Dip·109
[cm2·seg–1]
HD100/0-1
6.5 0.996 2.75 0.51 0.82
7.4 0.986 2.73 0.51 0.94
8.4 0.998 3.31 0.50 1.23
HD90/10-1
6.5 0.995 2.10 0.67 –
7.4 0.995 1.58 0.63 –
8.4 0.993 1.42 0.61 –
HD70/30-1
6.5 0.978 3.17 0.78 –
7.4 0.993 1.57 0.56 –
8.4 0.988 1.84 0.48 –
In principle the relation between the pH and the per-
centage of released R6G indicate that, while the
release mechanism can be similar for different pHs,
the final amount of drug released depends on the
medium’s pH and on the material’s swelling degree.
This behavior demonstrates the ability of such
copolymers to achieve a control of drug released as
a function of the pH of the medium.
3.5.2 Effect of cross-linking density
To evaluate the effect of cross-linker concentration
on the mechanism of the drug transport at pH 7.4
and 34.5°C, parameters (n, k) of the power law
model in Equation (3) are calculated (Table 4).
The release of Rh6G in pHEMA homopolymer at
pH 7.4 seems to follow a Fickian diffusion behavior
as suggested by values of n. However, by incorpo-
rating DPA, n values are close to 0.6 for all contents
and cross-linking densities, suggesting a non-Fick-
ian behavior.
The mechanism of Rh6G release does not seem to
be affected by increasing the cross-linking density
for the same copolymer composition, as judged by
n values. However, a reduction in the k parameter is
the most important effect of higher cross-linker
concentration. The decrease in kinetic constant val-
ues reflects the decrease in the rate of drug release,
which might be due to the dominance of chain
entanglement and the decrease in the water content
of polymers with different cross-linking densities.
By increasing the cross-linking density, pores are
smaller and less water is allowed to enter the matrix.
Since Rh6G is a water soluble molecule, this factor
has an important impact on drug rate. The larger
pore in the 1 wt% cross-linked copolymers allows
Rh6G diffusion with no or little resistance com-
pared to smaller one. Pore size is significantly
impacted by the extent of cross-linking and their
increasing values result in lower released kinetic.
This behavior could be an advantage in the case of
treatments where a prolonged therapy is required.
4. Conclusions
The incorporation of DPA confers pH-responsive
properties to the polymer, copolymers show a sig-
nificant increase of the swelling degree when the
pH decrease below 7.40 and reach the equilibrium
around pH 6.0. This effect is directly proportional
to the amount of present DPA in copolymers and
inversely proportional with the amount of cross -
linker. The apparent pKa of copolymers depend on
the composition of HEMA/DPA and the crosslink-
ing degree of hydrogels, and estimated values are
between 6.80 and 7.17. SEM images of copolymers
show important morphological changes when vary-
ing the medium pH according to swelling results. At
acid pH SEM imagines show an open morphology
state with a porous structure as a consequence of the
matrix expansion at this pH, while at basic pH show
a collapsed state due to lower swelling degree and a
more hydrophobic polymer. Hydrogels with 30 wt%
of DPA show higher pores than hydrogels with
10 wt%. For hydrogel HD100/0-1 no changes with
pH are appreciated and in all cases a compact sur-
face is observed.
Copolymers of HEMA and DPA, having good film
forming and physicochemical properties, were tested
as drug delivery systems using Rh6G as model drug.
The amount of Rh6G incorporated is higher for pure
pHEMA than for copolymers and depends mainly
on the medium pH and the interaction between the
drug and the copolymers’ matrix. The comparison
of FTIR spectra between loaded and unloaded films
indicates that Rh6G molecules interact with the OH
group of the HEMA by hydrogen bonding or through
dipole–dipole interaction. At pH 6.5, the total Rh6G
uptake is lower than at pH 8.4, and SEM imagines
show a greater accumulation on the surface at this
pH. Thus the loaded Rh6G is inversely proportional
with the swelling of the hydrogel and mainly depends
on the interaction between the drug and the matrix
of the copolymers. The total release of the drug
depends on the polymer composition and medium
pH. For pure pHEMA, the drug remains strongly
associated with the polymer chains inside the matrix
and, therefore, its release is very slow. On the other
hand, for copolymers, the total Rh6G released at
acid pH is higher than at basic pH, and it increases
as the proportion of DPA monomer increases. The
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Table 4. Parameters (k, n) calculated from the fit of Equa-
tion (4) for the Rh6G release from different cross-
linking densities at pH 7.4 and 34.5°C
Samples Cross-linking[wt%] R
2 k·103
[min–1] n
HD100/0
1 0.990 27.28 0.51
3 0.989 20.72 0.51
HD90/10
1 0.997 15.82 0.61
3 0.994 10.87 0.59
HD70/30
1 0.996 15.16 0.57
3 0.980 7.67 0.61
pore size observed from SEM images is highly cor-
related with the drug release behavior when varying
the medium pH. For copolymers, the release of the
Rh6G model drug in PBS follows a non-Fickian
diffusion process for pHs values less than or equal
to 7.4. The change of the polymer´s cross-linking
density affects only the drug release rate.
In conclusion, by changing the DPA content and the
degree of cross-linking density it is possible to mod-
ify kinetic parameters and, therefore, to control the
release kinetics depending on the medium pH.
Results show that copolymers of HEMA/DPA are
potentially useful as drug delivery systems for oph-
thalmic therapies.
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